Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-06-03

Clinical Trial Update: The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the safety and immunogenicity of a rotavirus vaccine when given together with MR or MMR vaccines.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Measles, Mumps, and Rubella vaccine (MMR) (Measles, Mumps, and Rubella vaccine)
  • Measles-Rubella vaccine (MR) (Measles-Rubella vaccine)
  • Rotavirus vaccine (rotavirus vaccine)

Snippet

Sponsor: Sichuan Center for Disease Control and Prevention | Conditions: Rotavirus | Phase 4 | Status: UNKNOWN